Literature DB >> 34787635

Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas.

Ashwin S Nathan1,2,3, Lin Yang2,3, Nancy Yang2,3, Lauren A Eberly1,2,3, Sameed Ahmed M Khatana1,2,3,4, Elias J Dayoub1,2,3, Sreekanth Vemulapalli5, Howard Julien1,2,3,4, David J Cohen6,7, Brahmajee K Nallamothu8, Suzanne J Baron9, Nimesh D Desai2,3,10, Wilson Y Szeto10, Howard C Herrmann1, Peter W Groeneveld2,3,4, Jay Giri1,2,3,4, Alexander C Fanaroff1,2,3.   

Abstract

Importance: Despite the benefits of high-technology therapeutics, inequitable access to these technologies may generate disparities in care. Objective: To examine the association between zip code-level racial, ethnic, and socioeconomic composition and rates of transcatheter aortic valve replacement (TAVR) among Medicare patients living within large metropolitan areas with TAVR programs. Design, Setting, and Participants: This multicenter, nationwide cross-sectional analysis of Medicare claims data between January 1, 2012, and December 31, 2018, included beneficiaries of fee-for-service Medicare who were 66 years or older living in the 25 largest metropolitan core-based statistical areas. Exposure: Receipt of TAVR. Main Outcomes and Measures: The association between zip code-level racial, ethnic, and socioeconomic composition and rates of TAVR per 100 000 Medicare beneficiaries.
Results: Within the studied metropolitan areas, there were 7590 individual zip codes. The mean (SD) age of Medicare beneficiaries within these areas was 71.4 (2.0) years, a mean (SD) of 47.6% (5.8%) of beneficiaries were men, and a mean (SD) of 4.0% (7.0%) were Asian, 11.1% (18.9%) were Black, 8.0% (12.9%) were Hispanic, and 73.8% (24.9%) were White. The mean number of TAVRs per 100 000 Medicare beneficiaries by zip code was 249 (IQR, 0-429). For each $1000 decrease in median household income, the number of TAVR procedures performed per 100 000 Medicare beneficiaries was 0.2% (95% CI, 0.1%-0.4%) lower (P = .002). For each 1% increase in the proportion of patients who were dually eligible for Medicaid services, the number of TAVR procedures performed per 100 000 Medicare beneficiaries was 2.1% (95% CI, 1.3%-2.9%) lower (P < .001). For each 1-unit increase in the Distressed Communities Index score, the number of TAVR procedures performed per 100 000 Medicare beneficiaries was 0.4% (95% CI, 0.2%-0.5%) lower (P < .001). Rates of TAVR were lower in zip codes with higher proportions of patients of Black race and Hispanic ethnicity, despite adjusting for socioeconomic markers, age, and clinical comorbidities. Conclusions and Relevance: Within major metropolitan areas in the US with TAVR programs, zip codes with higher proportions of Black and Hispanic patients and those with greater socioeconomic disadvantages had lower rates of TAVR, adjusting for age and clinical comorbidities. Whether this reflects a different burden of symptomatic aortic stenosis by race and socioeconomic status or disparities in use of TAVR requires further study.

Entities:  

Mesh:

Year:  2022        PMID: 34787635      PMCID: PMC8600460          DOI: 10.1001/jamacardio.2021.4641

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  28 in total

1.  2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Joseph E Bavaria; Carl L Tommaso; Ralph G Brindis; John D Carroll; G Michael Deeb; Ted E Feldman; Thomas G Gleason; Eric M Horlick; Clifford J Kavinsky; Dharam J Kumbhani; D Craig Miller; A Allen Seals; David M Shahian; Richard J Shemin; Thoralf M Sundt; Vinod H Thourani
Journal:  J Am Coll Cardiol       Date:  2018-07-18       Impact factor: 24.094

2.  Toward the Science and Practice of Anti-Racism: Launching a National Campaign Against Racism.

Authors:  Camara Phyllis Jones
Journal:  Ethn Dis       Date:  2018-08-09       Impact factor: 1.847

3.  Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report.

Authors:  Mohamad Alkhouli; David R Holmes; John D Carroll; Zhuokai Li; Taku Inohara; Andrzej S Kosinski; Molly Szerlip; Vinod H Thourani; Michael J Mack; Sreekanth Vemulapalli
Journal:  JACC Cardiovasc Interv       Date:  2019-05-27       Impact factor: 11.195

Review 4.  TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making.

Authors:  Megan Coylewright; John K Forrest; James M McCabe; Tamim M Nazif
Journal:  J Am Coll Cardiol       Date:  2020-03-17       Impact factor: 24.094

5.  Racial disparities and democratization of health care: A focus on TAVR in the United States.

Authors:  David R Holmes; Michael J Mack; Mohamad Alkhouli; Sreekanth Vemulapalli
Journal:  Am Heart J       Date:  2020-03-13       Impact factor: 4.749

6.  Racial and ethnic differences in the use of invasive cardiac procedures among cardiac patients in Los Angeles County, 1986 through 1988.

Authors:  D M Carlisle; B D Leake; M F Shapiro
Journal:  Am J Public Health       Date:  1995-03       Impact factor: 9.308

7.  2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.

Authors:  Michael J Reardon; David H Adams; Neal S Kleiman; Steven J Yakubov; Joseph S Coselli; G Michael Deeb; Thomas G Gleason; Joon Sup Lee; James B Hermiller; Stan Chetcuti; John Heiser; William Merhi; George L Zorn; Peter Tadros; Newell Robinson; George Petrossian; G Chad Hughes; J Kevin Harrison; Brijeshwar Maini; Mubashir Mumtaz; John V Conte; Jon R Resar; Vicken Aharonian; Thomas Pfeffer; Jae K Oh; Hongyan Qiao; Jeffrey J Popma
Journal:  J Am Coll Cardiol       Date:  2015-06-05       Impact factor: 24.094

8.  Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012-2018.

Authors:  Ashwin S Nathan; Lin Yang; Nancy Yang; Sameed Ahmed M Khatana; Elias J Dayoub; Lauren A Eberly; Sreekanth Vemulapalli; Suzanne J Baron; David J Cohen; Nimesh D Desai; Joseph E Bavaria; Howard C Herrmann; Peter W Groeneveld; Jay Giri; Alexander C Fanaroff
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-10-21

Review 9.  Racial and Ethnic Differences in Treatment and Outcomes of Severe Aortic Stenosis: A Review.

Authors:  Jimica B Wilson; Larry R Jackson; Francis E Ugowe; Terrell Jones; George S A Yankey; Colin Marts; Kevin L Thomas
Journal:  JACC Cardiovasc Interv       Date:  2020-01-27       Impact factor: 11.195

10.  Race/Ethnicity and Prevalence of Aortic Stenosis by Echocardiography in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Matthew J Czarny; Sanjiv J Shah; Seamus P Whelton; Michael J Blaha; Michael Y Tsai; Rimsky Denis; Alain Bertoni; Wendy S Post
Journal:  J Am Coll Cardiol       Date:  2021-05-11       Impact factor: 27.203

View more
  2 in total

1.  Disparities in Cardiovascular Mortality Between Black and White Adults in the United States, 1999 to 2019.

Authors:  Ashley N Kyalwazi; Eméfah C Loccoh; LaPrincess C Brewer; Elizabeth O Ofili; Jiaman Xu; Yang Song; Karen E Joynt Maddox; Robert W Yeh; Rishi K Wadhera
Journal:  Circulation       Date:  2022-07-18       Impact factor: 39.918

2.  What matters most to patients with severe aortic stenosis when choosing treatment? Framing the conversation for shared decision making.

Authors:  Nananda F Col; Diana Otero; Brian R Lindman; Aaron Horne; Melissa M Levack; Long Ngo; Kimberly Goodloe; Susan Strong; Elvin Kaplan; Melissa Beaudry; Megan Coylewright
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.